Prof. Dr. Taner KORKMAZ

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Neoadjuvant Pembrolizumab Plus Chemotherapy in Early-Stage Triple-Negative Breast Cancer: A Nationwide Retrospective Turkish Oncology Group Study

KARCI E., BİLİCİ A., Bayram B., Celayir M., Ozyurt N., OYAN ULUÇ B., et al.

CANCERS , sa.19, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy

Kilickap S., Ozturk A., Karadurmus N., Korkmaz T., Yumuk P. F., Cicin I., et al.

MEDICINE , cilt.103, sa.21, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

Recommendations for cyclin-dependent kinase 4/6 inhibitor treatments in the context of co-morbidity and drug interactions (Review)

Teomete M., ÇABUK D., Korkmaz T., Seber S., Ozturk O. F., Aver B., et al.

ONCOLOGY LETTERS , cilt.27, sa.4, 2024 (SCI-Expanded)

Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study

Hizal M., BİLGİN B., Paksoy N., Kilickap S., Atci M. M., Kahraman S., et al.

FUTURE ONCOLOGY , sa.23, ss.2573-2582, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

Pretreatment PET/CT Standardized Uptake Values Play a Role in Predicting Response to Treatment and Survival in Patients with Small Cell Lung Cancer

Dinc N. S., Aydin K., Odabas H., Ercelep O., Tufan G., ŞEKER M., et al.

ONCOLOGY RESEARCH AND TREATMENT , cilt.39, sa.3, ss.130-134, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective Analysis

Genestreti G., Tiseo M., Kenmotsu H., Kazushige W., Di Battista M., Cavallo G., et al.

CLINICAL LUNG CANCER , cilt.16, sa.6, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

Clinical Outcome of Turkish Metastatic Breast Cancer Patients with Currently Available Treatment Modalities - Single Center Experience

Cabuk D., BAŞARAN G., Teomete M., Dane F., Korkmaz T., Seber S., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.1, ss.117-122, 2014 (SCI-Expanded)

Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis

Korkmaz T., Seber S., KEFELİ U., Sari E., Canhoroz M., Oven B., et al.

CLINICAL & TRANSLATIONAL ONCOLOGY , cilt.15, sa.7, ss.535-540, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

Serum thymidine kinase 1 levels correlates with FDG uptake and prognosis in patients with non small cell lung cancer

Korkmaz T., Seber S., Okutur K., BAŞARAN G., Yumuk F., Dane F., et al.

BIOMARKERS , cilt.18, sa.1, ss.88-94, 2013 (SCI-Expanded)

Clinical outcome of breast cancer patients with N3a (>= 10 positive lymph nodes) disease: has it changed over years?

BAŞARAN G., Devrim C., Caglar H. B., GÜLLÜOĞLU M. B., KAYA H., Seber S., et al.

MEDICAL ONCOLOGY , cilt.28, sa.3, ss.726-732, 2011 (SCI-Expanded)

Diğer Dergilerde Yayınlanan Makaleler

Prevalence of K-Ras mutations in hepatocellular carcinoma: A Turkish Oncology Group pilot study

Turhal N. S., SAVAŞ B., COŞKUN Ö., Bas E., Karabulut B., Nart D., et al.

MOLECULAR AND CLINICAL ONCOLOGY , sa.6, ss.1275-1279, 2015 (ESCI)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler

COMPARISON OF GENESWELL BCT SCORE WITH ONCOTYPE DX RECURRENCE SCORE FOR RISK CLASSIFICATION IN TURKISH WOMEN WITH HORMONE RECEPTOR-POSITIVE, HER2- NEGATIVE, EARLY BREAST CANCER

URAS C., ARIKAN A. E., TOKAT F., KORKMAZ T., SAHAR A. A., SUBAŞI SEZGİN D.

Breastanbul, 6th Breast Cancer Conference, İstanbul, Türkiye, 10 - 12 Ekim 2024, cilt.15, (Özet Bildiri)

Metrikler

Yayın

Atıf (WoS)

251

H-İndeks (WoS)

Atıf (Scopus)

277

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler